Bansal, Ruchi <br/><br/>
Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.  [electronic resource] 

 -  Molecular pharmaceutics  Oct 2011 
 - 1899-909 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1543-8392 
<br/><br/><label>Standard No.: </label>10.1021/mp200263q  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biological Transport<br/>Cell Line<br/>Cells, Cultured<br/>Cross-Linking Reagents--chemistry<br/>Drug Carriers--adverse effects<br/>Female<br/>Hepatic Stellate Cells--drug effects<br/>Humans<br/>Interferon-gamma--administration & dosage<br/>Ligands<br/>Liver Cirrhosis--drug therapy<br/>Macrophage Activation--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Peptides, Cyclic--chemistry<br/>Receptor, Platelet-Derived Growth Factor beta--metabolism<br/>STAT1 Transcription Factor--metabolism<br/>Serum Albumin--chemistry<br/>Serum Albumin, Human<br/>Signal Transduction--drug effects<br/>Tissue Distribution